Jul. 27 at 12:52 AM
🚨MAIN WATCHLIST JULY 28th
$ONCO
Nanofloat of 220k with 45% short interest and a confirmed merger with Ocuvex. Volume surged 3.2x Friday and the chart is pressing breakout across all timeframes. One of the most explosive setups if momentum continues
$IXHL
Warrant cancellation, FDA clearance for Phase 3, and positive PK data confirm the catalyst chain is real. Float rotated on 222M volume and price is coiled tightly under breakout. This one is fully loaded.
$NCNA
Warrant cancellation confirmed and over 500M volume traded Friday. Same chart structure as its 2024 move from 0.05 to 0.17. High chance of another leg if volume returns
$ADIL
Patents granted, Phase 3 prep underway, and Nasdaq compliance regained. No debt or dilution, float under 15M, and a full biotech catalyst stack. Clean coil with strong upside if volume steps in
$TLIH
IPOed July 8 at
$4 and flushed to
$1. Now setting up for a clean reversal with no ATM, no S-1, and 80.32% insider ownership. Could bounce hard if buyers step in over key levels
⸻
🔥 Summary
Every setup here is real. Confirmed catalysts, low float, and breakout structure all lining up. ONCO and IXHL lead with volume and filings.NCNA has historical momentum. ADIL and TLIH offer strong biotech and IPO reversal setups. Let the trade come to you and stay sharp
